130 related articles for article (PubMed ID: 32825359)
1. Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.
Hussaarts KGAM; van Doorn L; Eechoute K; Damman J; Fu Q; van Doorn N; Eisenmann ED; Gibson AA; Oomen-de Hoop E; de Bruijn P; Baker SD; Koolen SLW; van Gelder T; van Leeuwen RWF; Mathijssen RHJ; Sparreboom A; Bins S
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32825359
[TBL] [Abstract][Full Text] [Related]
2. Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
Zimmerman EI; Gibson AA; Hu S; Vasilyeva A; Orwick SJ; Du G; Mascara GP; Ong SS; Chen T; Vogel P; Inaba H; Maitland ML; Sparreboom A; Baker SD
Cancer Res; 2016 Jan; 76(1):117-26. PubMed ID: 26677977
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies.
Inaba H; Panetta JC; Pounds SB; Wang L; Li L; Navid F; Federico SM; Eisenmann ED; Vasilyeva A; Wang YD; Shurtleff S; Pui CH; Gruber TA; Ribeiro RC; Rubnitz JE; Baker SD
Clin Cancer Res; 2019 Dec; 25(24):7320-7330. PubMed ID: 31455680
[TBL] [Abstract][Full Text] [Related]
4. Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers.
Macha S; Koenen R; Sennewald R; Schöne K; Hummel N; Riedmaier S; Woerle HJ; Salsali A; Broedl UC
Clin Ther; 2014 Feb; 36(2):280-90.e1. PubMed ID: 24491572
[TBL] [Abstract][Full Text] [Related]
5. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β3 -Adrenoceptor Agonist, With Probenecid in Healthy Men.
Abe Y; Nakano Y; Kanazawa T; Furihata T; Endo T; Kobayashi M
Clin Pharmacol Drug Dev; 2016 May; 5(3):201-7. PubMed ID: 27163499
[TBL] [Abstract][Full Text] [Related]
7. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Oswald S; König J; Lütjohann D; Giessmann T; Kroemer HK; Rimmbach C; Rosskopf D; Fromm MF; Siegmund W
Pharmacogenet Genomics; 2008 Jul; 18(7):559-68. PubMed ID: 18551036
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
9. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
[TBL] [Abstract][Full Text] [Related]
10. The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat.
Donovan MD; O'Brien FE; Boylan GB; Cryan JF; Griffin BT
J Pharm Pharmacol; 2015 Apr; 67(4):501-10. PubMed ID: 25490899
[TBL] [Abstract][Full Text] [Related]
11. Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humans.
Skarke C; Langer M; Jarrar M; Schmidt H; Geisslinger G; Lötsch J
Anesthesiology; 2004 Dec; 101(6):1394-9. PubMed ID: 15564947
[TBL] [Abstract][Full Text] [Related]
12. Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients.
Chang WT; Lu SN; Rau KM; Huang CS; Lee KT
Kaohsiung J Med Sci; 2018 Jul; 34(7):391-399. PubMed ID: 30063012
[TBL] [Abstract][Full Text] [Related]
13. Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.
Macdonald JI; Wallace SM; Herman RJ; Verbeeck RK
Eur J Clin Pharmacol; 1995; 47(6):519-23. PubMed ID: 7768255
[TBL] [Abstract][Full Text] [Related]
14. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
15. Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.
Hagos FT; Daood MJ; Ocque JA; Nolin TD; Bayir H; Poloyac SM; Kochanek PM; Clark RS; Empey PE
Xenobiotica; 2017 Apr; 47(4):346-353. PubMed ID: 27278858
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E
Shichiri H; Yamamoto K; Tokura M; Ishida T; Uda A; Bito T; Nishigori C; Nakagawa T; Hirano T; Yano I; Hirai M
Biochem Biophys Res Commun; 2017 Apr; 485(2):227-233. PubMed ID: 28237700
[TBL] [Abstract][Full Text] [Related]
17. Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline.
Davenport JM; Covington P; Bonifacio L; McIntyre G; Venitz J
J Clin Pharmacol; 2015 May; 55(5):534-42. PubMed ID: 25491493
[TBL] [Abstract][Full Text] [Related]
18. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.
Hesselink MB; Smolders H; Eilbacher B; De Boer AG; Breimer DD; Danysz W
J Pharmacol Exp Ther; 1999 Aug; 290(2):543-50. PubMed ID: 10411561
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats.
Karbownik A; Szkutnik-Fiedler D; Grabowski T; Wolc A; Stanisławiak-Rudowicz J; Jaźwiec R; Grześkowiak E; Szałek E
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959453
[TBL] [Abstract][Full Text] [Related]
20. A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine.
Infante JR; Jones SF; Bendell JC; Greco FA; Yardley DA; Lane CM; Spigel DR; Hainsworth JD; Burris HA
Cancer Chemother Pharmacol; 2012 Jan; 69(1):137-44. PubMed ID: 21626051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
